Cost effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post hoc economic analysis of phase 3 trial data

Cost effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post hoc economic analysis of phase 3 trial data

2015 19th International Congress of Parkinson's Disease and Movement Disorders

Francois, C. | Hauser, R. A. | Dorey, J. | Kharitonova, E. | Abalea, S. | Hewitt, L. A. | Volume: , Issue: , Pages: ,